Mardones Rodrigo, Jofré Claudio M, Minguell José J
Centro de Traumatología y Ortopedia, Laboratorio de Ingeniería de Tejidos, Clínica Las Condes, Santiago, Chile ; Centro de Terapia Regenerativa Celular, Laboratorio de Ingeniería de Tejidos, Clínica Las Condes, Santiago, Chile.
Centro de Terapia Regenerativa Celular, Laboratorio de Ingeniería de Tejidos, Clínica Las Condes, Santiago, Chile.
Int J Stem Cells. 2015 May;8(1):48-53. doi: 10.15283/ijsc.2015.8.1.48.
Articular cartilage injuries caused by traumatic, mechanical and/or by progressive degeneration result in pain, swelling, subsequent loss of joint function and finally osteoarthritis. Due to the peculiar structure of the tissue (no blood supply), chondrocytes, the unique cellular phenotype in cartilage, receive their nutrition through diffusion from the synovial fluid and this limits their intrinsic capacity for healing. The first cellular avenue explored for cartilage repair involved the in situ transplantation of isolated chondrocytes. Latterly, an improved alternative for the above reparative strategy involved the infusion of mesenchymal stem cells (MSC), which in addition to a self-renewal capacity exhibit a differentiation potential to chondrocytes, as well as a capability to produce a vast array of growth factors, cytokines and extracellular matrix compounds involved in cartilage development. In addition to the above and foremost reparative options up till now in use, other therapeutic options have been developed, comprising the design of biomaterial substrates (scaffolds) capable of sustaining MSC attachment, proliferation and differentiation. The implantation of these engineered platforms, closely to the site of cartilage damage, may well facilitate the initiation of an 'in situ' cartilage reparation process. In this mini-review, we examined the timely and conceptual development of several cell-based methods, designed to repair/regenerate a damaged cartilage. In addition to the above described cartilage reparative options, other therapeutic alternatives still in progress are portrayed.
由创伤、机械因素和/或进行性退变引起的关节软骨损伤会导致疼痛、肿胀、随后的关节功能丧失,最终发展为骨关节炎。由于组织的特殊结构(无血液供应),软骨细胞作为软骨中独特的细胞表型,通过从滑液中扩散来获取营养,这限制了它们自身的愈合能力。最初探索的软骨修复细胞途径涉及分离软骨细胞的原位移植。近来,上述修复策略的一种改进替代方法是输注间充质干细胞(MSC),间充质干细胞除了具有自我更新能力外,还具有向软骨细胞分化的潜能,以及产生大量参与软骨发育的生长因子、细胞因子和细胞外基质化合物的能力。除了上述目前正在使用的主要修复方法外,还开发了其他治疗选择,包括设计能够维持间充质干细胞附着、增殖和分化的生物材料基质(支架)。将这些工程化平台植入软骨损伤部位附近,很可能会促进“原位”软骨修复过程的启动。在这篇小型综述中,我们研究了几种旨在修复/再生受损软骨的基于细胞的方法的适时和概念性发展。此外,还描述了其他仍在进行中的治疗选择。